AR048347A1 - Vacuna contra la enfermedad periodontal - Google Patents

Vacuna contra la enfermedad periodontal

Info

Publication number
AR048347A1
AR048347A1 ARP050101226A ARP050101226A AR048347A1 AR 048347 A1 AR048347 A1 AR 048347A1 AR P050101226 A ARP050101226 A AR P050101226A AR P050101226 A ARP050101226 A AR P050101226A AR 048347 A1 AR048347 A1 AR 048347A1
Authority
AR
Argentina
Prior art keywords
vaccine against
periodontal disease
against periodontal
vaccines
polynucleotides
Prior art date
Application number
ARP050101226A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR048347A1 publication Critical patent/AR048347A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Aislamiento bacterianos identificados por su 16S ARNr ADN, que provocan la enfermedad periodontal en animales domésticos, secuencias de polinucleotidos y vacunas que comprenden dichas bacterias, polinucleotidos o polipéptidos. Método para evaluar la eficacia de una vacuna contra las enfermedades periodontales en un animal.
ARP050101226A 2004-05-21 2005-03-30 Vacuna contra la enfermedad periodontal AR048347A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/851,965 US7378101B2 (en) 2001-12-21 2004-05-21 Vaccine for periodontal disease

Publications (1)

Publication Number Publication Date
AR048347A1 true AR048347A1 (es) 2006-04-19

Family

ID=35058733

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101226A AR048347A1 (es) 2004-05-21 2005-03-30 Vacuna contra la enfermedad periodontal

Country Status (19)

Country Link
US (2) US7378101B2 (es)
EP (1) EP1753454B1 (es)
JP (1) JP4099213B2 (es)
CN (1) CN101014363A (es)
AR (1) AR048347A1 (es)
AT (1) ATE432082T1 (es)
AU (1) AU2005244663A1 (es)
BR (1) BRPI0510148A (es)
CA (1) CA2565925C (es)
DE (1) DE602005014635D1 (es)
ES (1) ES2325737T3 (es)
IL (1) IL178971A0 (es)
MX (1) MXPA06013471A (es)
NO (1) NO20065064L (es)
NZ (1) NZ550981A (es)
RU (1) RU2364417C2 (es)
TW (1) TW200538152A (es)
WO (1) WO2005112993A1 (es)
ZA (1) ZA200609105B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US7378101B2 (en) * 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US9181592B2 (en) * 2007-03-30 2015-11-10 Case Western Reserve University Method for detecting a bacterial pathogen
WO2008137506A2 (en) * 2007-05-01 2008-11-13 Mars Incorporated Methods and kits for dog plaque disease
JP2009173558A (ja) * 2008-01-22 2009-08-06 Gen Corp:Kk 抗イヌ歯周病組成物
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
RU2555342C2 (ru) * 2009-09-10 2015-07-10 Мериал Лимитед Новые вакцинные составы, включающие сапонинсодержащие адъюванты
RU2545530C2 (ru) * 2009-12-01 2015-04-10 Интервет Интернэшнл Б.В. Инактивированная вакцина для птицы
WO2012151272A2 (en) * 2011-05-02 2012-11-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
WO2013089166A1 (ja) * 2011-12-13 2013-06-20 学校法人麻布獣医学園 Porphyromonas gulaeの線毛タイプ
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
WO2015190589A1 (ja) * 2014-06-13 2015-12-17 学校法人麻布獣医学園 イヌの僧帽弁閉鎖不全症のリスク診断
JP2018154574A (ja) * 2017-03-16 2018-10-04 合同会社チューモス 点眼ワクチン及び免疫誘導方法
WO2019075260A1 (en) 2017-10-12 2019-04-18 Sutrovax, Inc. VACCINE AGAINST PERIODONTITIS AND ASSOCIATED COMPOSITIONS AND METHOD OF USE
US20210401914A1 (en) 2019-07-04 2021-12-30 Sosin Co., Ltd. Oral composition for animal and periodontal disease preventive, infection disease preventive, and mouth odor preventive using the oral composition
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN116751292B (zh) * 2023-07-31 2024-05-14 河南大学 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59128338A (ja) 1982-12-08 1984-07-24 Kitasato Inst:The 歯周炎予防用ワクチン及びその製法
JPH0662431B2 (ja) 1984-12-14 1994-08-17 ライオン株式会社 歯周炎予防用経口ワクチン
US5536497A (en) 1992-12-21 1996-07-16 The Research Foundation Of State University Of New York Fimbrial polypeptides useful in the prevention of periodontitis
JPH0797395A (ja) 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
WO1995010612A1 (fr) 1993-10-08 1995-04-20 Lion Corporation PROTEINE FIMBRILLINE DE $i(PORPHYROMONAS GINGIVALIS)
US5563063A (en) 1995-08-30 1996-10-08 Nihon University (Educational Foundation) Porphyromonas crevioricanis species of microorganism
US5710039A (en) 1995-08-30 1998-01-20 Nihon University (Educational Foundationn) Porphyromonas gingivicanis strain ATCC 55562
AUPQ137699A0 (en) * 1999-07-02 1999-07-22 University Of New England, The Control of acidosis
AUPQ718200A0 (en) 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
US7468185B2 (en) * 2001-12-21 2008-12-23 Pfizer Inc. Vaccine for periodontal disease
US7378101B2 (en) * 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease

Also Published As

Publication number Publication date
ATE432082T1 (de) 2009-06-15
BRPI0510148A (pt) 2007-10-02
US7378101B2 (en) 2008-05-27
JP2008500379A (ja) 2008-01-10
AU2005244663A1 (en) 2005-12-01
NZ550981A (en) 2009-07-31
CA2565925A1 (en) 2005-12-01
JP4099213B2 (ja) 2008-06-11
IL178971A0 (en) 2007-03-08
WO2005112993A1 (en) 2005-12-01
US20080311151A1 (en) 2008-12-18
EP1753454B1 (en) 2009-05-27
DE602005014635D1 (de) 2009-07-09
ZA200609105B (en) 2008-12-31
TW200538152A (en) 2005-12-01
CN101014363A (zh) 2007-08-08
RU2364417C2 (ru) 2009-08-20
EP1753454A1 (en) 2007-02-21
ES2325737T3 (es) 2009-09-15
NO20065064L (no) 2006-12-01
CA2565925C (en) 2011-01-18
MXPA06013471A (es) 2007-01-23
RU2006140984A (ru) 2008-05-27
US20050010032A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
AR048347A1 (es) Vacuna contra la enfermedad periodontal
IL184272A0 (en) Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
BRPI0509528A (pt) corpos imitação de glp-1 humana, composições, processos e usos
FR2898603B1 (fr) Nouveaux polyurethanes, compositions les comprenant et procede de traitement cosmetique
ECSP088787A (es) Vacuna de mycoplasma hyopneumoniae
DE602006015665D1 (de) Probiotische enterokokken für eine verbesserte immunität
BRPI0823271A2 (pt) Chip de dna, kit para detecção ou para genotipagem de bactérias que causam doenças sexualmente transmitidas, genotipagem de resistência a fármacos antibacterianos e método de detecção ou de genotipagem das mesmas.
BRPI0606363A2 (pt) método para o isolamento e/ou a purificação de ácidos nucleicos ácido nucleico, e, método para a imobilização de ácidos nucleicos em uma matriz
WO2003054755A3 (en) Vaccine for periodontal disease
AU2009326524A8 (en) Use of Flt3 ligand for strengthening immune responses in RNA immunization
EA201100413A1 (ru) Способ лечения бактериальной инфекции
ES2357692T3 (es) Multimero para la inmunoestimulacion.
DK1716234T3 (da) Substitueret, ikke-kodende nukleinsyremolekyle til terapeutisk og profylaktisk immunstimulering i mennesker og højerestående dyr
AR073482A2 (es) Enfermedad bacteriana de las aves de corral
BRPI0822947A2 (pt) Vacina recombinante, método para vacinação contra doenças de animais e método para identificação entre animais infectados e animais vacinados
NO20062469L (no) Streptococcus phocae vaksine
UY29544A1 (es) Tratamiento de enfermedades usando un sistema mejorado de expresión regulada
DK1295611T3 (da) Oligonukleotid-transformerende forbindelser
AR027926A1 (es) Vacunas de adn mejoradas para animales de granja
CL2007003660A1 (es) Uso de una bacteria del genero nocardia para fabricar una vacuna para combatir la infeccion bacteriana gram-negativa no nocardial en peces.
TW200608986A (en) Bioprotective agent
CL2021002213A1 (es) Formulación microbiana de intestino de abeja para su uso como un probiótico para salud mejorada y resistencia a patógenos de las abejas.
TW200517495A (en) Vaccine for periodontal disease
BRPI0607473A2 (pt) infecção por helicobacter em suìnos
FR2934777B1 (fr) Nouveaux polyurethanes, compositions les comprenant et procede de traitement cosmetique

Legal Events

Date Code Title Description
FA Abandonment or withdrawal